Ledger.Open graph →
SEC Form D · Amendment · filed February 12, 2019

Cellerant Therapeutics Inc

Offering
$10.0M
Sold
$6.5M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
SAN CARLOS, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (13)

Gisela G. Schwab · San Carlos, CADirectorStephen G. Greenberg · New York, NYDirectorRamkumar Mandalam · San Carlos, CAExec · DirectorRodney Young · San Carlos, CAExecNorman Jenkins · WASHINGTON, Washington, D.C.ExecRichard G. Rathmann · San Carlos, CADirectorRobby Hogle · San Carlos, CADirectorAlphonse J. Ruggiero · Holbrook, NYExec · DirectorDennis I. Schmal · Charlotte, NCDirectorJames I. Hille · Charlotte, NCDirectorBruce M. Stachenfeld · New York, NYExecRichard G. Rathmann · Annapolis, MDDirectorRobby Hogle · San Carlos, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗